AGIG

SEC source: 0001493152-26-031278 · ownership.xml · nonDerivative · entry 1

Harwood Lucie · CIK 0002075334 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 862,819

SEC source: 0001493152-26-030369 · ownership.xml · derivative · entry 1

Crawford Heitzmann Martha Jean · CIK 0002070456 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 131,870

Underlying: Common Stock · 131,870 shares

Expires 2036-06-25

F1 · shares: Such option was received as compensation for the reporting person's services as a member of the board of directors of the issuer and its exercise is subject to quarterly vesting over a period of twelve months from the date of grant. The reporting person disclaims beneficial ownership of such option and the shares of common stock issuable upon exercise thereof until its issuance pursuant to the issuer's 2025 Equity Incentive Plan.

F1 · derivative.exercise_date: Such option was received as compensation for the reporting person's services as a member of the board of directors of the issuer and its exercise is subject to quarterly vesting over a period of twelve months from the date of grant. The reporting person disclaims beneficial ownership of such option and the shares of common stock issuable upon exercise thereof until its issuance pursuant to the issuer's 2025 Equity Incentive Plan.

SEC source: 0001493152-26-030431 · ownership.xml · derivative · entry 1

Henninger Matthew T. · CIK 0002077971 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 131,870

Underlying: Common Stock · 131,870 shares

Expires 2036-06-25

F1 · shares: Such option was received as compensation for the reporting person's services as a member of the board of directors of the issuer and its exercise is subject to quarterly vesting over a period of twelve months from the date of grant. The reporting person disclaims beneficial ownership of such option and the shares of common stock issuable upon exercise thereof until its issuance pursuant to the issuer's 2025 Equity Incentive Plan.

F1 · derivative.exercise_date: Such option was received as compensation for the reporting person's services as a member of the board of directors of the issuer and its exercise is subject to quarterly vesting over a period of twelve months from the date of grant. The reporting person disclaims beneficial ownership of such option and the shares of common stock issuable upon exercise thereof until its issuance pursuant to the issuer's 2025 Equity Incentive Plan.

SEC source: 0001493152-26-030430 · ownership.xml · derivative · entry 1

LONGO PETER F. · CIK 0001508592 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 131,870

Underlying: Common Stock · 131,870 shares

Expires 2036-06-25

F1 · shares: Such option was received as compensation for the reporting person's services as a member of the board of directors of the issuer and its exercise is subject to quarterly vesting over a period of twelve months from the date of grant. The reporting person disclaims beneficial ownership of such option and the shares of common stock issuable upon exercise thereof until its issuance pursuant to the issuer's 2025 Equity Incentive Plan.

F1 · derivative.exercise_date: Such option was received as compensation for the reporting person's services as a member of the board of directors of the issuer and its exercise is subject to quarterly vesting over a period of twelve months from the date of grant. The reporting person disclaims beneficial ownership of such option and the shares of common stock issuable upon exercise thereof until its issuance pursuant to the issuer's 2025 Equity Incentive Plan.

SEC source: 0001493152-26-030429 · ownership.xml · derivative · entry 1

Bailey Robert J. · CIK 0001685251 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 131,870

Underlying: Common Stock · 131,870 shares

Expires 2036-06-25

F1 · shares: Such option was received as compensation for the reporting person's services as a member of the board of directors of the issuer and its exercise is subject to quarterly vesting over a period of twelve months from the date of grant. The reporting person disclaims beneficial ownership of such option and the shares of common stock issuable upon exercise thereof until its issuance pursuant to the issuer's 2025 Equity Incentive Plan.

F1 · derivative.exercise_date: Such option was received as compensation for the reporting person's services as a member of the board of directors of the issuer and its exercise is subject to quarterly vesting over a period of twelve months from the date of grant. The reporting person disclaims beneficial ownership of such option and the shares of common stock issuable upon exercise thereof until its issuance pursuant to the issuer's 2025 Equity Incentive Plan.

SEC source: 0001493152-26-028685 · ownership.xml · nonDerivative · entry 1

Gillespie Edward Oliver · CIK 0002076180 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 202,248

F1 · shares: Open market purchase by the reporting person of 11,000 shares of common stock, par value $0.001 per share.

SEC source: 0001493152-26-024597 · ownership.xml · nonDerivative · entry 1

Gillespie Edward Oliver · CIK 0002076180 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 191,248

F1 · shares: Open market purchase by the reporting person of 14,990 shares of common stock, par value $0.001 per share.

SEC source: 0001493152-26-023155 · ownership.xml · nonDerivative · entry 3

Gillespie Edward Oliver · CIK 0002076180 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 176,258

F5 · shares: Open market purchase by the reporting person of 13,000 shares of Common Stock.

SEC source: 0001493152-26-023155 · ownership.xml · nonDerivative · entry 2

Gillespie Edward Oliver · CIK 0002076180 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 163,258

F4 · shares: Open market purchase by the reporting person of 10,000 shares of Common Stock.

SEC source: 0001493152-26-023264 · ownership.xml · nonDerivative · entry 2

Bailey Robert J. · CIK 0001685251 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 105,875

F2 · shares: Open market purchase by the reporting person of 8,950 shares of Common Stock.

SEC source: 0001493152-26-023264 · ownership.xml · nonDerivative · entry 1

Bailey Robert J. · CIK 0001685251 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 96,925

F1 · shares: Open market purchase by the reporting person of 1,050 shares of common stock, par value $0.001 per share (the "Common Stock").

SEC source: 0001493152-26-023155 · ownership.xml · nonDerivative · entry 1

Gillespie Edward Oliver · CIK 0002076180 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 153,258

F1 · shares: Open market purchase by the reporting person of 8,220 shares of common stock, par value $0.001 per share (the "Common Stock").

F2 · price: Reflects the weighted average price of the shares purchased on the open market in multiple transactions on May 12, 2026 at prices ranging from $1.18 to $1.189 per share, inclusive.

F3 · price: The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of such shares of Common Stock purchased at each separate price within such range.

SEC source: 0001493152-26-023225 · ownership.xml · nonDerivative · entry 1

LONGO PETER F. · CIK 0001508592 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 108,916

F1 · shares: Open market purchase by the reporting person of 10,000 shares of common stock, par value $0.001 per share.

SEC source: 0001493152-26-005116 · ownership.xml · derivative · entry 1

Henninger Matthew T. · CIK 0002077971 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,582

Underlying: Common Stock · 33,582 shares

Expires 2036-02-03

F1 · shares: Such option was received as compensation for the reporting person's services as a member of the board of directors of the issuer and its exercise is subject to quarterly vesting over a period of twelve months from the date of grant. The reporting person disclaims beneficial ownership of such option and the shares of common stock issuable upon exercise thereof until its issuance pursuant to the issuer's 2025 Equity Incentive Plan.

F1 · derivative.exercise_date: Such option was received as compensation for the reporting person's services as a member of the board of directors of the issuer and its exercise is subject to quarterly vesting over a period of twelve months from the date of grant. The reporting person disclaims beneficial ownership of such option and the shares of common stock issuable upon exercise thereof until its issuance pursuant to the issuer's 2025 Equity Incentive Plan.

SEC source: 0001493152-26-005114 · ownership.xml · nonDerivative · entry 1

Crawford Heitzmann Martha Jean · CIK 0002070456 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,263

F1 · shares: Such shares of common stock were received as compensation for the reporting person's services as a member of the board of directors of the issuer and are subject to quarterly vesting over a period of twelve months from the date of grant. The reporting person disclaims beneficial ownership of such shares until their issuance pursuant to the issuer's 2025 Equity Incentive Plan.

F1 · price: Such shares of common stock were received as compensation for the reporting person's services as a member of the board of directors of the issuer and are subject to quarterly vesting over a period of twelve months from the date of grant. The reporting person disclaims beneficial ownership of such shares until their issuance pursuant to the issuer's 2025 Equity Incentive Plan.

SEC source: 0001493152-26-003484 · ownership.xml · nonDerivative · entry 1

Gillespie Edward Oliver · CIK 0002076180 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 145,038

F1 · shares: Such shares of common stock were received as compensation for the reporting person's services as an executive officer and member of the board of directors of the issuer and are subject to quarterly vesting over a period of twelve months from the date of grant. The reporting person disclaims beneficial ownership of such shares until their issuance pursuant to the issuer's 2025 Equity Incentive Plan.

F1 · price: Such shares of common stock were received as compensation for the reporting person's services as an executive officer and member of the board of directors of the issuer and are subject to quarterly vesting over a period of twelve months from the date of grant. The reporting person disclaims beneficial ownership of such shares until their issuance pursuant to the issuer's 2025 Equity Incentive Plan.

SEC source: 0001493152-26-003490 · ownership.xml · nonDerivative · entry 1

Crawford Heitzmann Martha Jean · CIK 0002070456 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,875

F1 · shares: Such shares of common stock were received as compensation for the reporting person's services as a member of the board of directors of the issuer and are subject to quarterly vesting over a period of twelve months from the date of grant. The reporting person disclaims beneficial ownership of such shares until their issuance pursuant to the issuer's 2025 Equity Incentive Plan.

F1 · price: Such shares of common stock were received as compensation for the reporting person's services as a member of the board of directors of the issuer and are subject to quarterly vesting over a period of twelve months from the date of grant. The reporting person disclaims beneficial ownership of such shares until their issuance pursuant to the issuer's 2025 Equity Incentive Plan.

SEC source: 0001493152-26-003482 · ownership.xml · nonDerivative · entry 1

Bailey Robert J. · CIK 0001685251 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 95,875

F1 · shares: Such shares of common stock were received as compensation for the reporting person's services as a member of the board of directors of the issuer and are subject to quarterly vesting over a period of twelve months from the date of grant. The reporting person disclaims beneficial ownership of such shares until their issuance pursuant to the issuer's 2025 Equity Incentive Plan.

F1 · price: Such shares of common stock were received as compensation for the reporting person's services as a member of the board of directors of the issuer and are subject to quarterly vesting over a period of twelve months from the date of grant. The reporting person disclaims beneficial ownership of such shares until their issuance pursuant to the issuer's 2025 Equity Incentive Plan.

SEC source: 0001493152-26-003480 · ownership.xml · nonDerivative · entry 1

Harwood Lucie · CIK 0002075334 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,843

F1 · shares: Such shares of common stock were received as compensation for the reporting person's services as an executive officer of the issuer and are subject to quarterly vesting over a period of twelve months from the date of grant. The reporting person disclaims beneficial ownership of such shares until their issuance pursuant to the issuer's 2025 Equity Incentive Plan.

F1 · price: Such shares of common stock were received as compensation for the reporting person's services as an executive officer of the issuer and are subject to quarterly vesting over a period of twelve months from the date of grant. The reporting person disclaims beneficial ownership of such shares until their issuance pursuant to the issuer's 2025 Equity Incentive Plan.

SEC source: 0001493152-26-003478 · ownership.xml · nonDerivative · entry 1

LONGO PETER F. · CIK 0001508592 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 98,916

F1 · shares: Such shares of common stock were received as compensation for the reporting person's services as a member of the board of directors of the issuer and are subject to quarterly vesting over a period of twelve months from the date of grant. The reporting person disclaims beneficial ownership of such shares until their issuance pursuant to the issuer's 2025 Equity Incentive Plan.

F1 · price: Such shares of common stock were received as compensation for the reporting person's services as a member of the board of directors of the issuer and are subject to quarterly vesting over a period of twelve months from the date of grant. The reporting person disclaims beneficial ownership of such shares until their issuance pursuant to the issuer's 2025 Equity Incentive Plan.

SEC source: 0001493152-26-003476 · ownership.xml · derivative · entry 1

Henninger Matthew T. · CIK 0002077971 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 41,812

Underlying: Common Stock · 41,812 shares

Expires 2036-01-21

F1 · shares: Such option was received as compensation for the reporting person's services as a member of the board of directors of the issuer and its exercise is subject to quarterly vesting over a period of twelve months from the date of grant. The reporting person disclaims beneficial ownership of such option and the shares of common stock issuable upon exercise thereof until its issuance pursuant to the issuer's 2025 Equity Incentive Plan.

F1 · derivative.exercise_date: Such option was received as compensation for the reporting person's services as a member of the board of directors of the issuer and its exercise is subject to quarterly vesting over a period of twelve months from the date of grant. The reporting person disclaims beneficial ownership of such option and the shares of common stock issuable upon exercise thereof until its issuance pursuant to the issuer's 2025 Equity Incentive Plan.

SEC source: 0001493152-26-003474 · ownership.xml · nonDerivative · entry 1

Gasik Joseph · CIK 0002075325 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,422

F1 · shares: Such shares of common stock were received as compensation for the reporting person's services as an executive officer of the issuer and are subject to quarterly vesting over a period of twelve months from the date of grant. The reporting person disclaims beneficial ownership of such shares until their issuance pursuant to the issuer's 2025 Equity Incentive Plan.

F1 · price: Such shares of common stock were received as compensation for the reporting person's services as an executive officer of the issuer and are subject to quarterly vesting over a period of twelve months from the date of grant. The reporting person disclaims beneficial ownership of such shares until their issuance pursuant to the issuer's 2025 Equity Incentive Plan.

SEC source: 0001493152-25-029395 · ownership.xml · nonDerivative · entry 1

Gillespie Edward Oliver · CIK 0002076180 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,961

F1 · shares: Open market purchase by the reporting person of 12,500 shares of common stock, par value $0.001 per share (the "Common Stock").

F2 · price: Reflects the weighted average price of the shares purchased on the open market in multiple transactions on December 23, 2025 at prices ranging from $1.85 to $1.96 per share, inclusive.

F3 · price: The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of such shares of Common Stock purchased at each separate price within such range.

SEC source: 0001493152-25-029132 · ownership.xml · nonDerivative · entry 2

Gillespie Edward Oliver · CIK 0002076180 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 38,461

F4 · shares: Open market purchase by the reporting person of 30,000 shares of Common Stock.

F3 · price: The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of such shares of Common Stock purchased at each separate price within such range.

F5 · price: Reflects the weighted average price of the shares of Common Stock purchased on the open market in multiple transactions on December 22, 2025 at prices ranging from $1.76 to $1.94 per share, inclusive.

SEC source: 0001493152-26-001177 · ownership.xml · nonDerivative · entry 2

Bailey Robert J. · CIK 0001685251 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 68,000

F2 · shares: Open market purchase by the reporting person of 2,000 shares of Common Stock.

SEC source: 0001493152-26-001902 · ownership.xml · nonDerivative · entry 2

LONGO PETER F. · CIK 0001508592 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 71,041

F4 · shares: Open market purchase by the reporting person of 5,000 shares of Common Stock.

SEC source: 0001493152-25-029134 · ownership.xml · nonDerivative · entry 1

Henninger Matthew T. · CIK 0002077971 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,500

F1 · shares: Open market purchase by the reporting person of 9,500 shares of common stock, par value $0.001 per share.

SEC source: 0001493152-25-029132 · ownership.xml · nonDerivative · entry 1

Gillespie Edward Oliver · CIK 0002076180 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,461

F1 · shares: Open market purchase by the reporting person of 8,461 shares of common stock, par value $0.001 per share (the "Common Stock").

F2 · price: Reflects the weighted average price of the shares purchased on the open market in multiple transactions on December 19, 2025 at prices ranging from $1.60 to $1.72 per share, inclusive.

F3 · price: The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of such shares of Common Stock purchased at each separate price within such range.

SEC source: 0001493152-26-001177 · ownership.xml · nonDerivative · entry 1

Bailey Robert J. · CIK 0001685251 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 66,000

F1 · shares: Open market purchase by the reporting person of 10,000 shares of common stock, par value $0.001 per share (the "Common Stock").

SEC source: 0001493152-26-001902 · ownership.xml · nonDerivative · entry 1

LONGO PETER F. · CIK 0001508592 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 66,041

F1 · shares: Open market purchase by the reporting person of 26,041 shares of common stock, par value $0.001 per share (the "Common Stock").

F2 · price: Reflects the weighted average price of the shares purchased on the open market in multiple transactions on December 19, 2025 at prices ranging from $1.59 to $1.69 per share, inclusive.

F3 · price: The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of such shares of Common Stock purchased at each separate price within such range.

SEC source: 0000950170-25-094110 · ownership.xml · nonDerivative · entry 1

Bower Family Holdings, LLC · CIK 0002045197 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,246,760

F1 · price: The Reporting Person exchanged all of its units of Abundia Global Impact Group, LLC in exchange for the indicated shares of common stock, par value $0.001, of Houston American Energy Corp. ("HUSA") pursuant to the Share Exchange Agreement, dated February 20, 2025, by and among the HUSA, Abundia Financial LLC and the Reporting Person, as amended.

SEC source: 0000950170-25-097893 · ownership.xml · nonDerivative · entry 1

Bower Family Holdings, LLC · CIK 0002045197 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,284,598

F1 · price: The Reporting Person exchanged all of its units of Abundia Global Impact Group, LLC in exchange for the indicated shares of common stock, par value $0.001, of Houston American Energy Corp. ("HUSA") pursuant to the Share Exchange Agreement, dated February 20, 2025, by and among the HUSA, Abundia Financial LLC and the Reporting Person, as amended.

F2 · balance_after: This amended Form 4 is being filed to correct the amount reported in Item 5 of Table I of the Reporting Person's original Form 4, filed on July 3, 2025, to account for the 10-to-1 reverse stock split effected by HUSA on June 6, 2025.

SEC source: 0001685251-25-000003 · primary_doc.xml · nonDerivative · entry 1

Bailey Robert J. · CIK 0001685251 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 57,500

F1 · shares: The Board approved the issuance of these shares pending approval of a future equity incentive plan. The shares have not been issued and will not be issued until shareholders approve a future equity incentive plan. Mr. Bailey disclaims beneficial ownership of these shares.

F1 · price: The Board approved the issuance of these shares pending approval of a future equity incentive plan. The shares have not been issued and will not be issued until shareholders approve a future equity incentive plan. Mr. Bailey disclaims beneficial ownership of these shares.

F1 · balance_after: The Board approved the issuance of these shares pending approval of a future equity incentive plan. The shares have not been issued and will not be issued until shareholders approve a future equity incentive plan. Mr. Bailey disclaims beneficial ownership of these shares.

SEC source: 0001508592-25-000010 · primary_doc.xml · nonDerivative · entry 1

LONGO PETER F. · CIK 0001508592 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 51,917.48

F1 · shares: The Board approved the issuance of these shares pending approval of a future equity incentive plan. The shares have not been issued and will not be issued until shareholders approve a future equity incentive plan. Mr. Longo disclaims beneficial ownership of these shares.

F1 · price: The Board approved the issuance of these shares pending approval of a future equity incentive plan. The shares have not been issued and will not be issued until shareholders approve a future equity incentive plan. Mr. Longo disclaims beneficial ownership of these shares.

F1 · balance_after: The Board approved the issuance of these shares pending approval of a future equity incentive plan. The shares have not been issued and will not be issued until shareholders approve a future equity incentive plan. Mr. Longo disclaims beneficial ownership of these shares.

SEC source: 0001493152-26-001174 · ownership.xml · nonDerivative · entry 1

Bailey Robert J. · CIK 0001685251 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 56,000

F1 · date: This Form 4 amendment is being filed by the reporting person in order to correct the transaction date in the Form 4 filed by the reporting person with the U.S. Securities and Exchange Commission ("SEC") on July 1, 2025 (the "Original Form 4"). On June 27, 2025, the board of directors of the issuer approved the grant of the shares of the issuer's common stock, par value $0.001 per share (the "Common Stock"), reported in the Original Form 4. Accordingly, the date in Column 2 of the Original Form 4 is hereby amended to June 27, 2025.

F2 · balance_after: This Form 4 amendment is also being filed by the reporting person in order to correct the total number of shares of Common Stock beneficially owned and reported in the Original Form 4, which erroneously included 1,500 shares of Common Stock issuable upon exercise of stock options previously awarded to the reporting person and reported in Table II of the Form 4 filed by the reporting person with the SEC on January 17, 2025, on a pre-reverse stock split basis. Accordingly, the number of shares of Common Stock reported in Column 5 of Table I of the Original Form 4 is hereby amended to 56,000 shares of Common Stock

SEC source: 0001493152-26-001897 · ownership.xml · nonDerivative · entry 1

LONGO PETER F. · CIK 0001508592 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,000

F1 · date: This Form 4 amendment is being filed by the reporting person in order to correct the transaction date in the Form 4 filed by the reporting person with the U.S. Securities and Exchange Commission ("SEC") on July 1, 2025 (the "Original Form 4"). On June 27, 2025, the board of directors of the issuer approved the grant of the shares of the issuer's common stock, par value $0.001 per share (the "Common Stock"), reported in the Original Form 4. Accordingly, the date in Column 2 of the Original Form 4 is hereby amended to June 27, 2025.

F2 · balance_after: This Form 4 amendment is also being filed by the reporting person in order to correct the total number of shares of Common Stock beneficially owned and reported in the Original Form 4, which erroneously included 11,917.48 shares of Common Stock issuable upon exercise of stock options previously awarded to the reporting person and reported in Table II of the Form 4 filed by the reporting person with the SEC on June 17, 2025. Accordingly, the number of shares of Common Stock reported in Column 5 of Table I of the Original Form 4 is hereby amended to 40,000 shares of Common Stock.

SEC source: 0001508592-25-000009 · primary_doc.xml · derivative · entry 6

LONGO PETER F. · CIK 0001508592 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,917.48

Underlying: Common Stock · 1,415.09 shares

Expires 2035-06-17

F11 · shares: On June 17, 2025, the reporting person received a grant of options to acquire a number of shares of the Company's common stock equal to $15,000 divided by the then trading price per share of the Company's common stock, which was $10.60 per share (the trading price for the last business day before the grant date). Therefore, on June 17, 2025, 1,415.09 options were granted to the reporting person.

F12 · derivative.exercise_date: The options were granted on June 17, 2025 and are exercisable six months from the date of grant. The options vest 20% on the date of grant and 80% nine months from the date of grant.

F12 · derivative.expiration_date: The options were granted on June 17, 2025 and are exercisable six months from the date of grant. The options vest 20% on the date of grant and 80% nine months from the date of grant.

F11 · derivative.underlying_shares: On June 17, 2025, the reporting person received a grant of options to acquire a number of shares of the Company's common stock equal to $15,000 divided by the then trading price per share of the Company's common stock, which was $10.60 per share (the trading price for the last business day before the grant date). Therefore, on June 17, 2025, 1,415.09 options were granted to the reporting person.

SEC source: 0001508592-25-000008 · primary_doc.xml · derivative · entry 5

LONGO PETER F. · CIK 0001508592 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 105,023.92

Underlying: Common Stock · 22,058.82 shares

Expires 2035-05-15

F9 · shares: On May 15, 2025, the reporting person received a grant of options to acquire a number of shares of the Company's common stock equal to $15,000 divided by the then trading price per share of the Company's common stock, which was $0.68 per share (the trading price for the last business day before the grant date). Therefore, on May 15, 2025, 22,058.82 options were granted to the reporting person.

F10 · derivative.exercise_date: The options were granted on May 15, 2025 and are exercisable six months from the date of grant. The options vest 20% on the date of grant and 80% nine months from the date of grant.

F10 · derivative.expiration_date: The options were granted on May 15, 2025 and are exercisable six months from the date of grant. The options vest 20% on the date of grant and 80% nine months from the date of grant.

F9 · derivative.underlying_shares: On May 15, 2025, the reporting person received a grant of options to acquire a number of shares of the Company's common stock equal to $15,000 divided by the then trading price per share of the Company's common stock, which was $0.68 per share (the trading price for the last business day before the grant date). Therefore, on May 15, 2025, 22,058.82 options were granted to the reporting person.

SEC source: 0001508592-25-000009 · primary_doc.xml · derivative · entry 5

LONGO PETER F. · CIK 0001508592 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,502.39

Underlying: Common Stock · 2,205.88 shares

Expires 2035-05-15

F13 · derivative.exercise_price: Reflects the 10-for-1 reverse stock split effected by the Company which became market effective on June 9, 2025.

F9 · shares: On May 15, 2025, the reporting person received a grant of options to acquire a number of shares of the Company's common stock equal to $15,000 divided by the then trading price per share of the Company's common stock, which was $0.68 per share (the trading price for the last business day before the grant date). Therefore, on May 15, 2025, 22,058.82 options were granted to the reporting person. Since the date of issue, the Company effected a 10-for-1 reverse stock split which became market effective on June 9, 2025. The number of options initially issued was 10 times more than the number set forth in the table above and the exercise price was 1/10th of the price set forth in the table. As a result, the number of shares for which the options are exercisable and the exercise price in the above table have been adjusted to reflect the 10-to-1 reverse stock split.

F13 · shares: Reflects the 10-for-1 reverse stock split effected by the Company which became market effective on June 9, 2025.

F10 · derivative.exercise_date: The options were granted on May 15, 2025 and are exercisable six months from the date of grant. The options vest 20% on the date of grant and 80% nine months from the date of grant.

F10 · derivative.expiration_date: The options were granted on May 15, 2025 and are exercisable six months from the date of grant. The options vest 20% on the date of grant and 80% nine months from the date of grant.

F9 · derivative.underlying_shares: On May 15, 2025, the reporting person received a grant of options to acquire a number of shares of the Company's common stock equal to $15,000 divided by the then trading price per share of the Company's common stock, which was $0.68 per share (the trading price for the last business day before the grant date). Therefore, on May 15, 2025, 22,058.82 options were granted to the reporting person. Since the date of issue, the Company effected a 10-for-1 reverse stock split which became market effective on June 9, 2025. The number of options initially issued was 10 times more than the number set forth in the table above and the exercise price was 1/10th of the price set forth in the table. As a result, the number of shares for which the options are exercisable and the exercise price in the above table have been adjusted to reflect the 10-to-1 reverse stock split.

F13 · derivative.underlying_shares: Reflects the 10-for-1 reverse stock split effected by the Company which became market effective on June 9, 2025.

F13 · balance_after: Reflects the 10-for-1 reverse stock split effected by the Company which became market effective on June 9, 2025.

SEC source: 0001508592-25-000007 · primary_doc.xml · derivative · entry 4

LONGO PETER F. · CIK 0001508592 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 82,965.1

Underlying: Common Stock · 26,787.71 shares

Expires 2035-04-15

F7 · shares: On April 15, 2025, the reporting person received a grant of options to acquire a number of shares of the Company's common stock equal to $15,000 divided by the then trading price per share of the Company's common stock, which was $0.56 per share (the trading price for the last business day before the grant date). Therefore, on April 15, 2025, 26,785.71 options were granted to the reporting person.

F8 · derivative.exercise_date: The options were granted on April 15, 2025 and are exercisable six months from the date of grant. The options vest 20% on the date of grant and 80% nine months from the date of grant.

F8 · derivative.expiration_date: The options were granted on April 15, 2025 and are exercisable six months from the date of grant. The options vest 20% on the date of grant and 80% nine months from the date of grant.

F7 · derivative.underlying_shares: On April 15, 2025, the reporting person received a grant of options to acquire a number of shares of the Company's common stock equal to $15,000 divided by the then trading price per share of the Company's common stock, which was $0.56 per share (the trading price for the last business day before the grant date). Therefore, on April 15, 2025, 26,785.71 options were granted to the reporting person.

SEC source: 0001508592-25-000008 · primary_doc.xml · derivative · entry 4

LONGO PETER F. · CIK 0001508592 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 82,965.1

Underlying: Common Stock · 26,785.71 shares

Expires 2035-04-15

F7 · shares: On April 15, 2025, the reporting person received a grant of options to acquire a number of shares of the Company's common stock equal to $15,000 divided by the then trading price per share of the Company's common stock, which was $0.56 per share (the trading price for the last business day before the grant date). Therefore, on April 15, 2025, 26,785.71 options were granted to the reporting person.

F8 · derivative.exercise_date: The options were granted on April 15, 2025 and are exercisable six months from the date of grant. The options vest 20% on the date of grant and 80% nine months from the date of grant.

F8 · derivative.expiration_date: The options were granted on April 15, 2025 and are exercisable six months from the date of grant. The options vest 20% on the date of grant and 80% nine months from the date of grant.

F7 · derivative.underlying_shares: On April 15, 2025, the reporting person received a grant of options to acquire a number of shares of the Company's common stock equal to $15,000 divided by the then trading price per share of the Company's common stock, which was $0.56 per share (the trading price for the last business day before the grant date). Therefore, on April 15, 2025, 26,785.71 options were granted to the reporting person.

SEC source: 0001508592-25-000009 · primary_doc.xml · derivative · entry 4

LONGO PETER F. · CIK 0001508592 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,296.51

Underlying: Common Stock · 2,678.57 shares

Expires 2035-04-15

F13 · derivative.exercise_price: Reflects the 10-for-1 reverse stock split effected by the Company which became market effective on June 9, 2025.

F7 · shares: On April 15, 2025, the reporting person received a grant of options to acquire a number of shares of the Company's common stock equal to $15,000 divided by the then trading price per share of the Company's common stock, which was $0.56 per share (the trading price for the last business day before the grant date). Therefore, on April 15, 2025, 26,785.71 options were granted to the reporting person. Since the date of issue, the Company effected a 10-for-1 reverse stock split which became market effective on June 9, 2025. The number of options initially issued was 10 times more than the number set forth in the table above and the exercise price was 1/10th of the price set forth in the table. As a result, the number of shares for which the options are exercisable and the exercise price in the above table have been adjusted to reflect the 10-to-1 reverse stock split.

F13 · shares: Reflects the 10-for-1 reverse stock split effected by the Company which became market effective on June 9, 2025.

F8 · derivative.exercise_date: The options were granted on April 15, 2025 and are exercisable six months from the date of grant. The options vest 20% on the date of grant and 80% nine months from the date of grant.

F8 · derivative.expiration_date: The options were granted on April 15, 2025 and are exercisable six months from the date of grant. The options vest 20% on the date of grant and 80% nine months from the date of grant.

F7 · derivative.underlying_shares: On April 15, 2025, the reporting person received a grant of options to acquire a number of shares of the Company's common stock equal to $15,000 divided by the then trading price per share of the Company's common stock, which was $0.56 per share (the trading price for the last business day before the grant date). Therefore, on April 15, 2025, 26,785.71 options were granted to the reporting person. Since the date of issue, the Company effected a 10-for-1 reverse stock split which became market effective on June 9, 2025. The number of options initially issued was 10 times more than the number set forth in the table above and the exercise price was 1/10th of the price set forth in the table. As a result, the number of shares for which the options are exercisable and the exercise price in the above table have been adjusted to reflect the 10-to-1 reverse stock split.

F13 · derivative.underlying_shares: Reflects the 10-for-1 reverse stock split effected by the Company which became market effective on June 9, 2025.

F13 · balance_after: Reflects the 10-for-1 reverse stock split effected by the Company which became market effective on June 9, 2025.

SEC source: 0001508592-25-000005 · primary_doc.xml · derivative · entry 3

LONGO PETER F. · CIK 0001508592 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 56,179.39

Underlying: Common Stock · 14,018.69 shares

Expires 2035-03-15

F5 · shares: On March 15, 2025, the reporting person received a grant of options to acquire a number of shares of the Company's common stock equal to $15,000 divided by the then trading price per share of the Company's common stock, which was $1.07 per share (the trading price for the last business day before the grant date). Therefore, on March 15, 2025, 14,018.69 options were granted to the reporting person.

F6 · derivative.exercise_date: The options were granted on March 15, 2025 and are exercisable six months from the date of grant. The options vest 20% on the date of grant and 80% nine months from the date of grant.

F6 · derivative.expiration_date: The options were granted on March 15, 2025 and are exercisable six months from the date of grant. The options vest 20% on the date of grant and 80% nine months from the date of grant.

F5 · derivative.underlying_shares: On March 15, 2025, the reporting person received a grant of options to acquire a number of shares of the Company's common stock equal to $15,000 divided by the then trading price per share of the Company's common stock, which was $1.07 per share (the trading price for the last business day before the grant date). Therefore, on March 15, 2025, 14,018.69 options were granted to the reporting person.

SEC source: 0001508592-25-000007 · primary_doc.xml · derivative · entry 3

LONGO PETER F. · CIK 0001508592 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 56,179.39

Underlying: Common Stock · 14,018.69 shares

Expires 2035-03-15

F5 · shares: On March 15, 2025, the reporting person received a grant of options to acquire a number of shares of the Company's common stock equal to $15,000 divided by the then trading price per share of the Company's common stock, which was $1.07 per share (the trading price for the last business day before the grant date). Therefore, on March 15, 2025, 14,018.69 options were granted to the reporting person.

F6 · derivative.exercise_date: The options were granted on March 15, 2025 and are exercisable six months from the date of grant. The options vest 20% on the date of grant and 80% nine months from the date of grant.

F6 · derivative.expiration_date: The options were granted on March 15, 2025 and are exercisable six months from the date of grant. The options vest 20% on the date of grant and 80% nine months from the date of grant.

F5 · derivative.underlying_shares: On March 15, 2025, the reporting person received a grant of options to acquire a number of shares of the Company's common stock equal to $15,000 divided by the then trading price per share of the Company's common stock, which was $1.07 per share (the trading price for the last business day before the grant date). Therefore, on March 15, 2025, 14,018.69 options were granted to the reporting person.

SEC source: 0001508592-25-000008 · primary_doc.xml · derivative · entry 3

LONGO PETER F. · CIK 0001508592 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 56,179.39

Underlying: Common Stock · 14,018.69 shares

Expires 2035-03-15

F5 · shares: On March 15, 2025, the reporting person received a grant of options to acquire a number of shares of the Company's common stock equal to $15,000 divided by the then trading price per share of the Company's common stock, which was $1.07 per share (the trading price for the last business day before the grant date). Therefore, on March 15, 2025, 14,018.69 options were granted to the reporting person.

F6 · derivative.exercise_date: The options were granted on March 15, 2025 and are exercisable six months from the date of grant. The options vest 20% on the date of grant and 80% nine months from the date of grant.

F6 · derivative.expiration_date: The options were granted on March 15, 2025 and are exercisable six months from the date of grant. The options vest 20% on the date of grant and 80% nine months from the date of grant.

F5 · derivative.underlying_shares: On March 15, 2025, the reporting person received a grant of options to acquire a number of shares of the Company's common stock equal to $15,000 divided by the then trading price per share of the Company's common stock, which was $1.07 per share (the trading price for the last business day before the grant date). Therefore, on March 15, 2025, 14,018.69 options were granted to the reporting person.

SEC source: 0001508592-25-000009 · primary_doc.xml · derivative · entry 3

LONGO PETER F. · CIK 0001508592 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,617.93

Underlying: Common Stock · 1,401.87 shares

Expires 2035-03-15

F13 · derivative.exercise_price: Reflects the 10-for-1 reverse stock split effected by the Company which became market effective on June 9, 2025.

F5 · shares: On March 15, 2025, the reporting person received a grant of options to acquire a number of shares of the Company's common stock equal to $15,000 divided by the then trading price per share of the Company's common stock, which was $1.07 per share (the trading price for the last business day before the grant date). Therefore, on March 15, 2025, 14,018.69 options were granted to the reporting person. Since the date of issue, the Company effected a 10-for-1 reverse stock split which became market effective on June 9, 2025. The number of options initially issued was 10 times more than the number set forth in the table above and the exercise price was 1/10th of the price set forth in the table. As a result, the number of shares for which the options are exercisable and the exercise price in the above table have been adjusted to reflect the 10-to-1 reverse stock split.

F13 · shares: Reflects the 10-for-1 reverse stock split effected by the Company which became market effective on June 9, 2025.

F6 · derivative.exercise_date: The options were granted on March 15, 2025 and are exercisable six months from the date of grant. The options vest 20% on the date of grant and 80% nine months from the date of grant.

F6 · derivative.expiration_date: The options were granted on March 15, 2025 and are exercisable six months from the date of grant. The options vest 20% on the date of grant and 80% nine months from the date of grant.

F5 · derivative.underlying_shares: On March 15, 2025, the reporting person received a grant of options to acquire a number of shares of the Company's common stock equal to $15,000 divided by the then trading price per share of the Company's common stock, which was $1.07 per share (the trading price for the last business day before the grant date). Therefore, on March 15, 2025, 14,018.69 options were granted to the reporting person. Since the date of issue, the Company effected a 10-for-1 reverse stock split which became market effective on June 9, 2025. The number of options initially issued was 10 times more than the number set forth in the table above and the exercise price was 1/10th of the price set forth in the table. As a result, the number of shares for which the options are exercisable and the exercise price in the above table have been adjusted to reflect the 10-to-1 reverse stock split.

F13 · derivative.underlying_shares: Reflects the 10-for-1 reverse stock split effected by the Company which became market effective on June 9, 2025.

F13 · balance_after: Reflects the 10-for-1 reverse stock split effected by the Company which became market effective on June 9, 2025.

SEC source: 0001508592-25-000004 · primary_doc.xml · derivative · entry 2

LONGO PETER F. · CIK 0001508592 · Director · CEO, President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 42,160.7

Underlying: Common Stock · 10,638.3 shares

Expires 2035-02-15

F3 · shares: On February 15, 2025, the reporting person received a grant of options to acquire a number of shares of the Company's common stock equal to $15,000 divided by the then trading price per share of the Company's common stock, which was $1.41 per share (the trading price for the last business day before the grant date). Therefore, on February 15, 2025, 10,638.30 options were granted to the reporting person.

F4 · derivative.exercise_date: The options were granted on February 15, 2025 and are exercisable six months from the date of grant. The options vest 20% on the date of grant and 80% nine months from the date of grant.

F4 · derivative.expiration_date: The options were granted on February 15, 2025 and are exercisable six months from the date of grant. The options vest 20% on the date of grant and 80% nine months from the date of grant.

F3 · derivative.underlying_shares: On February 15, 2025, the reporting person received a grant of options to acquire a number of shares of the Company's common stock equal to $15,000 divided by the then trading price per share of the Company's common stock, which was $1.41 per share (the trading price for the last business day before the grant date). Therefore, on February 15, 2025, 10,638.30 options were granted to the reporting person.

SEC source: 0001508592-25-000005 · primary_doc.xml · derivative · entry 2

LONGO PETER F. · CIK 0001508592 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 42,160.7

Underlying: Common Stock · 10,638.3 shares

Expires 2035-02-15

F3 · shares: On February 15, 2025, the reporting person received a grant of options to acquire a number of shares of the Company's common stock equal to $15,000 divided by the then trading price per share of the Company's common stock, which was $1.41 per share (the trading price for the last business day before the grant date). Therefore, on February 15, 2025, 10,638.30 options were granted to the reporting person.

F4 · derivative.exercise_date: The options were granted on February 15, 2025 and are exercisable six months from the date of grant. The options vest 20% on the date of grant and 80% nine months from the date of grant.

F4 · derivative.expiration_date: The options were granted on February 15, 2025 and are exercisable six months from the date of grant. The options vest 20% on the date of grant and 80% nine months from the date of grant.

F3 · derivative.underlying_shares: On February 15, 2025, the reporting person received a grant of options to acquire a number of shares of the Company's common stock equal to $15,000 divided by the then trading price per share of the Company's common stock, which was $1.41 per share (the trading price for the last business day before the grant date). Therefore, on February 15, 2025, 10,638.30 options were granted to the reporting person.

SEC source: 0001508592-25-000007 · primary_doc.xml · derivative · entry 2

LONGO PETER F. · CIK 0001508592 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 42,160.7

Underlying: Common Stock · 10,638.3 shares

Expires 2035-02-15

F3 · shares: On February 15, 2025, the reporting person received a grant of options to acquire a number of shares of the Company's common stock equal to $15,000 divided by the then trading price per share of the Company's common stock, which was $1.41 per share (the trading price for the last business day before the grant date). Therefore, on February 15, 2025, 10,638.30 options were granted to the reporting person.

F4 · derivative.exercise_date: The options were granted on February 15, 2025 and are exercisable six months from the date of grant. The options vest 20% on the date of grant and 80% nine months from the date of grant.

F4 · derivative.expiration_date: The options were granted on February 15, 2025 and are exercisable six months from the date of grant. The options vest 20% on the date of grant and 80% nine months from the date of grant.

F3 · derivative.underlying_shares: On February 15, 2025, the reporting person received a grant of options to acquire a number of shares of the Company's common stock equal to $15,000 divided by the then trading price per share of the Company's common stock, which was $1.41 per share (the trading price for the last business day before the grant date). Therefore, on February 15, 2025, 10,638.30 options were granted to the reporting person.

SEC source: 0001508592-25-000008 · primary_doc.xml · derivative · entry 2

LONGO PETER F. · CIK 0001508592 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 42,160.7

Underlying: Common Stock · 10,638.3 shares

Expires 2035-02-15

F3 · shares: On February 15, 2025, the reporting person received a grant of options to acquire a number of shares of the Company's common stock equal to $15,000 divided by the then trading price per share of the Company's common stock, which was $1.41 per share (the trading price for the last business day before the grant date). Therefore, on February 15, 2025, 10,638.30 options were granted to the reporting person.

F4 · derivative.exercise_date: The options were granted on February 15, 2025 and are exercisable six months from the date of grant. The options vest 20% on the date of grant and 80% nine months from the date of grant.

F4 · derivative.expiration_date: The options were granted on February 15, 2025 and are exercisable six months from the date of grant. The options vest 20% on the date of grant and 80% nine months from the date of grant.

F3 · derivative.underlying_shares: On February 15, 2025, the reporting person received a grant of options to acquire a number of shares of the Company's common stock equal to $15,000 divided by the then trading price per share of the Company's common stock, which was $1.41 per share (the trading price for the last business day before the grant date). Therefore, on February 15, 2025, 10,638.30 options were granted to the reporting person.